Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STERIS plc Director's Dealing 2021

Oct 5, 2021

30229_dirs_2021-10-05_84105554-0611-4d49-ad08-008c34b25f83.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2021-10-01

Reporting Person: Fraser Mary Clare (Vice President & Chief HRO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-10-01 Ordinary Shares A 692 $0.00 Acquired 5458 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-10-01 Employee Stock Option (right to buy) $228.36 A 3784 Acquired 2031-10-01 Ordinary Shares (3784) Direct

Footnotes

F1: All 692 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse on October 1, 2025.

F2: 4,901 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 791 on June 1, 2022; 791 on June 1, 2023; 791 on June 1, 2024; 1,836 on June 2, 2025 and 692 on October 1, 2025.

F3: This option becomes exercisable as follows: 946 on October 3, 2022; 946 on October 2, 2023; 946 on October 1, 2024 and 946 on October 1, 2025.